Last edition
News about Drug Discovery & Development
The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs
These miniature organs are used to develop therapies against incurable diseases.
Drug Discovery & Development | 11/05/2022 | By Content editor | 1049
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members